Compare MDU & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDU | LNTH |
|---|---|---|
| Founded | 1924 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.4B |
| IPO Year | N/A | 2015 |
| Metric | MDU | LNTH |
|---|---|---|
| Price | $20.10 | $65.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $22.00 | ★ $78.00 |
| AVG Volume (30 Days) | ★ 2.0M | 731.2K |
| Earning Date | 02-05-2026 | 02-25-2026 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.93 | ★ 2.39 |
| Revenue | ★ $1,875,100,000.00 | $1,525,933,000.00 |
| Revenue This Year | $10.52 | $0.01 |
| Revenue Next Year | $3.45 | $0.26 |
| P/E Ratio | ★ $21.87 | $27.12 |
| Revenue Growth | ★ 6.66 | 1.95 |
| 52 Week Low | $15.04 | $47.25 |
| 52 Week High | $21.49 | $111.29 |
| Indicator | MDU | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 46.58 | 47.15 |
| Support Level | $20.12 | $65.24 |
| Resistance Level | $21.28 | $68.70 |
| Average True Range (ATR) | 0.44 | 2.08 |
| MACD | -0.06 | -0.36 |
| Stochastic Oscillator | 9.69 | 34.70 |
MDU Resources Group Inc operates in three business segments, which include the electric segment, which generates, transmits, and distributes electricity in Montana, North Dakota, South Dakota, and Wyoming; The natural gas distribution segment distributes natural gas in those states, as well as in Idaho, Minnesota, Oregon, and Washington; The pipeline segment provides natural gas transportation and underground storage services through a regulated pipeline system in the Rocky Mountain and northern Great Plains regions of the United States.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.